Blue Trust’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$516 Buy
+49
New +$719 ﹤0.01% 2282
2026
Q1
– Sell
-10
Closed -$286 – 2641
2025
Q4
$286 Buy
10
+5
+100% +$135 ﹤0.01% 2458
2025
Q3
$147 Sell
5
-1,962
-100% -$53.6K ﹤0.01% 2524
2025
Q2
$56.7K Buy
1,967
+623
+46% +$18.4K ﹤0.01% 1368
2025
Q1
$47K Buy
1,344
+51
+4% +$2.08K ﹤0.01% 1396
2024
Q4
$57.6K Buy
1,293
+844
+188% +$34.5K ﹤0.01% 1216
2024
Q3
$14.9K Buy
449
+290
+182% +$11.7K ﹤0.01% 2059
2024
Q2
$7.62K Buy
+159
New +$6.5K ﹤0.01% 2031
2024
Q1
– Sell
-156
Closed -$11K – 2606
2023
Q4
$11K Buy
156
+21
+16% +$1.42K ﹤0.01% 1556
2023
Q3
$11K Buy
135
+37
+38% +$2.96K ﹤0.01% 1390
2023
Q2
$8K Sell
98
-1,174
-92% -$103K ﹤0.01% 1390
2023
Q1
$109K Buy
1,272
+950
+295% +$82.7K ﹤0.01% 740
2022
Q4
$23K Buy
322
+93
+41% +$7.88K ﹤0.01% 1250
2022
Q3
$22K Buy
229
+160
+232% +$14.3K ﹤0.01% 1063
2022
Q2
$8K Buy
+69
New +$7.03K ﹤0.01% 1292

Other funds holding QDEL

Blue Trust's QDEL Position: Q3 2026 in Review

Blue Trust opened a new position in QuidelOrtho (QDEL) in Q3 2026: 49 shares worth $516. The stake represents ﹤0.01% of the portfolio and ranks #2282 among its holdings. This is a return to the name: Blue Trust previously reported a position in QDEL as recently as Q4 2025.

Blue Trust first reported a position in QDEL in Q2 2022 and has held it in 15 quarters since. The position peaked at $109K in Q1 2023. 181 funds tracked by Wall St. Rank hold QDEL as of Q3 2026.

  • Blue Trust held 49 shares of QuidelOrtho worth $516 as of Q3 2026.
  • QuidelOrtho was a new Blue Trust position in Q3 2026.
  • QuidelOrtho made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2282 holding.
  • Blue Trust first reported a position in QuidelOrtho in Q2 2022 and has held it in 15 quarters since.
  • Blue Trust's QuidelOrtho position peaked at $109K in Q1 2023.
  • 181 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.